共 314 条
[1]
Pfisterer M(2009)BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial JAMA 301 383-392
[2]
Buser P(2011)Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 32-43
[3]
Rickli H(2020)Reappraising the role of inflammation in heart failure Nat Rev Cardiol 17 269-285
[4]
Gutmann M(2020)Inflammation in heart failure: JACC state-of-the-art review J Am Coll Cardiol 75 1324-1340
[5]
Erne P(2004)Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL) Circulation 109 1594-1602
[6]
Rickenbacher P(2003)Anti TNFTACHFI: Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial Circulation 107 3133-3140
[7]
Vuillomenet A(2019)Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure Circulation 139 1289-1299
[8]
Jeker U(2013)Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 1268-1277
[9]
Dubach P(2011)Fibrinogen and cardiovascular disease: genetics and biomarkers Blood Rev 25 239-245
[10]
Beer H(2000)Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations J Clin Endocrinol Metab 85 3121-3125